The origin of the fatty acid activation and formaldehyde dehydrogenase activity that distinguishes human class III alcohol dehydrogenase (alcohol:NAD+ oxidoreductase, EC 1.1.1.1) from all other alcohol dehydrogenases has been examined by site-directed mutagenesis of its Arg-115
capable of oxidizing formaldehyde in a glutathione (GSH)-dependent reaction (3, 4) . Moreover, its Km for ethanol is >3 M compared to 1 mM for class I isozymes; yet, it is nearly as effective as other ADHs toward long-chain primary alcohols, particularly w-hydroxy fatty acids such as 12-hydroxydodecanoate (12-HDA) (5) . It is totally insensitive to inhibition by 4-methylpyrazole, a potent inhibitor of the class I and II enzymes.
An additional feature unique to yr-ADH is its activation by hydrophobic anions, particularly fatty acids, which can stimulate both alcohol oxidation and aldehyde reduction up to 30-fold (5) . The nonessential activator mechanism proposed for this process indicates that the alcohol substrate and the activator bind simultaneously, with consequent enhancement of substrate binding. The degree of activation is optimal when the sum of the fatty acid plus alcohol chain lengths is 9 or 10 carbons. Thus, ethanol oxidation is activated maximally by octanoate, pentanol by pentanoate, and octanol by acetate. This complementarity likely reflects the length of the substrate binding pocket of the ADHs (6, 7) . Appropriate combinations of activator and alcohol side chains apparently fit into this pocket (5) and result in maximal activity. The observations that all activators require an anionic group and that the best substrates for XX-ADH, 12 -HDA and S-hydroxymethylglutathione (HMGSH) , have an co-carboxylate group suggested that a corresponding positively charged residue would be located close to the active site. The most likely candidate is Arg-115, which recently has been implicated as a binding locus for both activators and HMGSH: its modification by phenylglyoxal diminishes both fatty acid activation and formaldehyde dehydrogenase (FDH) activity (J.-M. Moulis, B.H., K.E., and B.L.V., unpublished data), and it is located in this region of the enzyme. The charged nature of the substrate binding site of class III ADH has also been noted in sequence comparisons and computer graphics modeling (6) . When an activator binds to fill the region of the pocket not occupied by the substrate, its carboxylate group would interact with this positively charged arginine. This model could also account for the FDH activity of XX-ADH since oxidation of HMGSH, the actual substrate formed spontaneously from GSH and formaldehyde, would be facilitated by interaction of one of its two carboxyl groups with Arg-115, thereby aligning its primary hydroxyl with the active site zinc.
Here we report the kinetic characterization of human class III ADH altered at position 115 
MATERIALS AND METHODS
Plasmid Constructions. The entire coding cDNA for human class III ADH was excised from plasmid p3OL (8) with EcoRI and Ssp I and was expressed (M.E., unpublished data) in the same system that was used for class I ADH (9, 10 RilSA, R115D, and rXx-ADH. The latter was required for comparison since XX-ADH isolated from human liver is acetylated at the N terminus (15) , whereas the recombinant enzymes are not (9) . Anion-exchange HPLC was used as the final purification step (5) to obtain homogeneous products with a yield of -1 mg of protein per 2 liters of culture. These eluted at slightly different retention times (Table 1) in accord with the changes in charge introduced at position 115. Thus, rXX-ADH elutes earlier than XX-ADH, consistent with its unblocked N terminus and the Asp mutant elutes somewhat later owing to the introduction of a negative charge. SDS/ PAGE (data not shown) indicates that all of the enzymes are >95% homogeneous.
Kinetic Characterization. The kinetic effects of the mutations were assessed with both neutral and charged alcohols and with HMGSH generated from GSH and formaldehyde (Table 2) . For all substrates examined, the kinetic constants for ryX-ADH are essentially the same as those of yX-ADH. Expression of rXx-ADH and its two mutants, R115D and R115A, in E. coli was accomplished with the system devised for the class I isozymes (10) and other human class III ADH mutants (M.E., unpublished data). The activities of the two mutants toward ethanol were essentially unchanged (Table 2) compared to XX-ADH, and their behavior during purification was consistent with the changes made in amino acid composition. The absence of acetylated N termini of the recombinant proteins as well as the mutations from the positively charged Arg to Ala and Asp affect the total charge of the protein and, hence, their respective elution times from the HPLC ion-exchange column (Table 1) . Furthermore, affinity chromatography on AMP-Sepharose indicates that in both cases the coenzyme binding site is intact and, hence, that this part of the enzymes has folded correctly. Although E. coli produces an endogenous class III alcohol dehydrogenase homologous to the human enzyme (17) , the E. coli enzyme has a pl of 4.4 compared to 6.4 for the human protein (2) , and it would be well separated from any of the mutants; indeed, it was not observed in these preparations. The (6) and are unlikely to be involved in enzyme activity or fatty acid activation. This can be judged from computer modeling studies, which have shown that the main chain of class III ADH can be built without major changes to the known crystal structure of the horse EE isozyme and which allow distances between residues to be determined (6) . Several The latter has been ascribed to additional mutations, primarily in the size and hydrophobicity of the active site pocket, which improve the capacity to bind short-chain alcohols and, in particular, to oxidize ingested ethanol more effectively (6) . The capacity to metabolize short-chain alcohols by class III ADH is very low owing to poor substrate binding and has been acquired by the other classes that diverged from this early enzyme.
In summary, mutagenesis of human class III ADH has identified a residue, Arg-115, that is largely responsible for two of its unique functional properties, the capacity to oxidize HMGSH and the activation by fatty acids. The results lead to a common mechanism that explains both of these activities. Although not a catalytic residue, Arg-115 plays a definitive role in establishing the specificity of this ADH. It allows an co-carboxy-substituted hydrophobic moiety, be it from the substrate or an activator, to achieve full occupancy of the active site pocket, which thereby increases the catalytic efficiency ofthe XX-ADH oxidation process. The optimal size of activator/substrate pairs for fatty acid activation and of hemithiolacetals for FDH activity is dictated by the dimensions of the active site pocket. The preference of the enzyme for long, hydrophobic anionic substrates; the increase in activity toward MCA; and loss of both FDH activity as well as activation by fatty acids when the arginine is blocked by modification by phenylglyoxal are all consistent with the requirement for a positively charged residue at position 115.
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